Fourteen patients with poor-risk acute myelogenous leukaemia (AML) and five patients with accelerated phase/blast crisis chronic myeloid leukaemia (CML) were treated with 3 days of oral idarubicin (25 mg/m2/ day). No complete remissions or return to chronic phase CML were observed. A fall in the per
Prognostic value of chromosomal findings in the blast phase of Ph1-positive chronic myeloid leukaemia (CML)
✍ Scribed by ÉVa Oláh; Kálmán Rák
- Publisher
- John Wiley and Sons
- Year
- 1981
- Tongue
- French
- Weight
- 584 KB
- Volume
- 27
- Category
- Article
- ISSN
- 0020-7136
No coin nor oath required. For personal study only.
✦ Synopsis
Abstract
Twenty‐three patients in various cytological subgroups of blast phase of Ph^1^‐positive chronic myeloid leukaemia were investigated cytogenetically. The correlation between prognosis and the cytological and cytogenetic features of blast cells was studied. The best prognosis was found in the myeloid group, followed by the lymphoid, myelomonocytic, megakaryoblastic and finally the promyelocytic groups, in this order. As regards the prognostic significance of the cytogenetic finding, the survival seemed to be the longest among patients with mosaic karyotypes i.e. when further aberrations occurred in some Ph^1^‐positive cells. The course of the disease was the most favourable in the presence of i(17q), especially in patients whose cells had i(17q) as the only aberration. The most severe course of the disease could be found in patients with +8 and/or two Ph^1^. The results demonstrate the usefulness of chromosome investigations in distinguishing the different cytogenetic subgroups in terminal stages of CML, which also differ prognostically from each other.
📜 SIMILAR VOLUMES
The therapeutic response and survival after the onset of the acute crisis in 64 patients with Phipositive chronic myeloid leukemia (CML) were correlated with the chromosomal findings during the course ofthe acute phase. The patients were divided into three groups on the basis ofthe chromosome findin
Cytogenetic analysis is the gold standard for the follow-up of CML patients. The sensitivity of cytogenetics is fairly similar to that of Southern detection of M-BCR rearrangement (5%); this last technique has the potential advantage of being independent of cell division and yield of metaphases. IFN